Skip to content

Clinical trials

Esophageal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Country / region: China Clear all

483 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20041
20074
20084
20097
20108
20118
201213
20137
201413
201526
201626
201728
201820
201923
202026
202131
202246
202344
202457
202556
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status165
Recruiting135
Completed112
Not yet recruiting26
Active, not recruiting21
Withdrawn9
Terminated7
Enrolling by invitation7
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University25
Fudan University23
Chinese Academy of Medical Sciences22
Cancer Institute and Hospital, Chinese Academy of Medical Sciences21
Tianjin Medical University Cancer Institute and Hospital20
Shanghai Chest Hospital12
Zhejiang Cancer Hospital12
Zhejiang University12
Henan Cancer Hospital10
Shanghai Zhongshan Hospital9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms483
Stomach Neoplasms70
Esophageal Squamous Cell Carcinoma55
Lung Neoplasms33
Pancreatic Neoplasms28
Colorectal Neoplasms26
Breast Neoplasms24
Carcinoma, Non-Small-Cell Lung19
Neoplasms17
Ovarian Neoplasms17

Trials

Showing 51 to 75 of 483. Each trial links to its page on Pharma Observatory.

383 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.